Please login to the form below

Not currently logged in
Email:
Password:

Valeant acquires Swiss pharma company

Canada's Valeant Pharmaceuticals has signed a deal to acquire Swiss firm PharmaSwiss S.A. for €350m in a move to strengthen its European presence

Canada's Valeant Pharmaceuticals International has signed a deal to acquire the privately held Swiss firm PharmaSwiss S.A. for €350m in a move to strengthen its European presence.

PharmaSwiss, which specialises in branded generics and over-the-counter (OTC) drugs, is based in Zug, Switzerland, and has operations in 19 countries throughout Central and Eastern Europe, including Poland, Hungary, the Czech Republic and Serbia. The company had revenues of about €180m in 2010 and has been growing at an annual rate of about 20 per cent over the past five years.

PharmaSwiss' senior management team will remain in place after the closing of the acquisition, working closely with the Valeant Europe team. Eventually, Valeant plans to fold its business in Central Europe into the PharmaSwiss corporate structure.

Valeant expects operating income as a percentage of revenue of the combined Central and Eastern European business to be similar to that of Valeant's historical branded generic European business.

The deal is expected to close before the end of the second quarter of 2011 and to be immediately accretive to Valeant. 

Valeant said it was attracted to the Swiss firm because of its active partnering strategy and complementary branded generics and OTC product portfolio. PharmaSwiss has partnerships with multinational companies including Amgen, Astellas, Bristol-Myers Squibb, Ferring, Ipsen, Lilly, Norgine, and Pfizer.

Valeant develops and markets pharmaceuticals with a focus on neurology, dermatology and branded generics. The company as it currently exists was created last year when the Canadian pharma company Biovail acquired the US-based company called Valeant, creating the merged company that now operates under the name.

2nd February 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....